Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: A meta-analysis

Annals of Pharmacotherapy

Volumn 39, Issue 9, 2005, Pages 1409-1415

  Gillespie, Effie L ^a,b   Coleman, Craig I ^a,b   Sander, Stephen ^a,b   Kluger, Jeffrey ^b,c,d   Gryskiewicz, Kristen A ^a,b   White, C Michael ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

^c Arrhythmia Service and Coronary Intensive Care Unit

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Amiodarone; Atrial fibrillation; Cardiothoracic surgery

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO;

ADULT; AGED; CELL HETEROGENEITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ECONOMIC ASPECT; ELECTROCARDIOGRAM; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE SURGERY; HOLTER MONITORING; HOSPITAL COST; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY ANALYSIS; STROKE; SYSTEMATIC REVIEW; THORAX SURGERY;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART VALVES; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, ECONOMIC; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; THORACIC SURGICAL PROCEDURES;

EID: 23944452302     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E592     Document Type: Review

References (24)

1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9.
2. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-66.
3. Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 2004;147:636-43.
4. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomized, double blind, placebo controlled trial. Br Heart J 1993;70:56-60.
5. Daoud EG, Strickberger SA, Man C, Goyal R, Debb GM, Bolling SF, et al. Preoperadve amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-91.
6. Dorge H, Schoendube FA, Schoberer M, Stellbrink C, Voss M, Messmer BJ. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg 2000;69:1358-62.
7. Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery. The Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial. Lancet 2001;357:830-6.
8. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry D. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 1999;34:343-7.
9. Hohnloser SH, Meinertz T, Dammbacher T, Steiert K, Jahnchen E, Zehender M, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121:89-95.
10. Lee SH, Chang CM, Lu MJ, Lee RJ, Cheng JJ, Hung CR, et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2000;70:157-61.
11. Maras D, Boskovic SD, Popovic Z, Neskovic AN, Kovacevic S, Otasevic P, et al. Single-day loading dose of oral amiodarone for the prevention of new onset atrial fibrillation after coronary artery bypass surgery. Am Heart J 2001;14:e8.
12. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, et al. Prophylactic amiodarone for the prevention of arrhythmias that begin early after revascularization, valvular repair, or replacement (PA-PABEAR): preliminary results (abstract). Circulation 2003;108:2723.
13. Redle JD, Khurana S, Marzan R, McCullough PA, Stewart JA, Westveer DC, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999;138:144-50.
14. White CM, Caron MF, Kalus JS, Rose H, Song J, Reddy P, et al. Intravenous plus oral amiodarone. atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II(AFIST II). Circulation 2003;108(suppl II):II-200-6.
15. Treggiari-Venzi MM, Waeber JL, Perneger TV, Suter PM, Adamec R, Romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000;85:690-5.
16. Yagdi T, Nalbantgil S, Ayik F, Apaydin A, Islamoglu F, Posacioglu H, et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1420-5.
17. Yazigi A, Rahbani P, Zeid HA, Madi-Jebara S, Haddad F, Hayek G. Post-operative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. J Cardiothorac Vascu Anesth 2002;16:603-6.
18. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002;106:75-80.
19. Zimmer J, Pezzullo J, Choucair W, Southard J, Kokkinos P, Karasik P, et al. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, cost, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 2003;91:1137-40.
20. Dickerson K, Scherer R, Lefebvre C. Systematic reviews: identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996;17:1-12.
22. Kerstein J, Soodan A, Qamar M, Majid M, Lichstein E, Hollander G, et al. Giving iv and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 2004;126:716-24.
23. Press release. Do PAPABEAR results support use of amiodarone prophylaxis to prevent postoperative atrial fibrillation? www.medscape. com/viewarticle/ 464772 (accessed 2004 Jun 1).
24. Buckley MS, Nolan PE, Slack MK, Tisdale JB, Hilleman DE, Copeland JG. Prophylactic amiodarone decreases atrial fibrillation and hospital length of stay following cardiac surgery: a meta-analysis (abstract). Pharmacotherapy 2004;24:1426.